IVZ
50
-5
AVGO
88
27
FLS
69
-2
JPM
59
-3
FMC
37
-2
AZO
62
4
KMX
66
-2
GIS
49
12
FDX
34
-2
EXR
48
-3
TAP
60
2
SBUX
32
-9
PNC
53
-2
AAP
29
-3
PRU
45
-2
JNJ
36
3
O
19
-12
AXP
69
2
STX
42
-2
FTI
76
3
IVZ
50
-5
AVGO
88
27
FLS
69
-2
JPM
59
-3
FMC
37
-2
AZO
62
4
KMX
66
-2
GIS
49
12
FDX
34
-2
EXR
48
-3
TAP
60
2
SBUX
32
-9
PNC
53
-2
AAP
29
-3
PRU
45
-2
JNJ
36
3
O
19
-12
AXP
69
2
STX
42
-2
FTI
76
3
Financhill
Back

Keros Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
15

KROS
Keros Therapeutics

Last Price:
18.85
Seasonality Move:
14.46%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
15
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $18.83. The Score for KROS is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $18.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.62 Sell
Relative Strength Index (14 RSI): 22.69 Sell
Chaikin Money Flow: -1326968 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.05 - 70.43) Sell
Bollinger Bands (100): (46.62 - 63.56) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.22 Sell
20-day SMA: 55.96 Sell
50-day SMA: 59.16 Sell
200-day SMA: 55.11 Sell
8-day EMA: 47 Sell
20-day EMA: 54.67 Sell
50-day EMA: 56.98 Sell
200-day EMA: 53.66 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.18 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):